$262 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 9 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 22.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | BRAZE INC | $140,758,000 | – | 3,394,219 | +100.0% | 53.76% | – | |
PMVP | PMV PHARMACEUTICALS INC | $67,351,000 | -9.9% | 3,234,911 | 0.0% | 25.73% | -41.8% | |
GKOS | GLAUKOS CORP | $20,252,000 | +30.1% | 350,264 | 0.0% | 7.74% | -15.9% | |
REAL | THE REALREAL | $17,091,000 | -37.5% | 2,354,080 | 0.0% | 6.53% | -59.6% | |
SERA PROGNOSTICS | $9,158,000 | -44.8% | 2,416,241 | 0.0% | 3.50% | -64.3% | ||
EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $4,656,000 | +17.3% | 560,990 | -26.7% | 1.78% | -24.2% |
AGTC | APPLIED GENETIC TECHNOL CORP | $1,503,000 | -43.7% | 1,404,515 | 0.0% | 0.57% | -63.6% | |
VERO | VENUS CONCEPT INC | $942,000 | -15.9% | 658,657 | 0.0% | 0.36% | -45.6% | |
DARE | DARE BIOSCIENCE INC | $92,000 | -25.8% | 62,065 | 0.0% | 0.04% | -52.1% | |
AI | Exit | C3.AIcl a | $0 | – | -866,774 | -100.0% | -16.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-04-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLAUKOS CORP | 27 | Q2 2023 | 33.0% |
EIGER BIOPHARMACEUTICALS INC | 24 | Q3 2022 | 17.7% |
APPLIED GENETIC TECHNOL CORP | 24 | Q3 2022 | 6.7% |
XENON PHARMACEUTICALS INC | 20 | Q3 2021 | 0.6% |
CIDARA THERAPEUTICS INC | 19 | Q2 2021 | 4.5% |
THE REALREAL | 17 | Q2 2023 | 62.6% |
KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 10.8% |
DARE BIOSCIENCE INC | 15 | Q2 2023 | 0.3% |
MACROGENICS INC | 14 | Q1 2020 | 19.2% |
PMV PHARMACEUTICALS INC | 12 | Q2 2023 | 67.5% |
View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-07-21 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-31 |
13F-HR | 2022-10-25 |
13F-HR | 2022-08-02 |
13F-HR | 2022-04-13 |
13F-HR | 2022-01-25 |
13F-HR | 2021-10-19 |
13F-HR | 2021-07-26 |
13F-HR | 2021-04-15 |
View INTERWEST VENTURE MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.